Skip to main content
Quest Diagnostics

Treatment and Coaching Experience from Individuals with Relapsed/Refractory Multiple Myeloma: Qualitative Insights During Treatment with Isatuximab

ASH 2023

American Society of Hematology

San Diego, CA Dec 9-12, 2023

Poster presentation: Treatment and Coaching Experience from Individuals with Relapsed/Refractory Multiple Myeloma: Qualitative Insights During Treatment with Isatuximab

Authors: Brassil K, Banerjee R, Barr A, Grossfeld T, Manasanch E

Specialty: Oncology, Hematology

Disclaimer: One or more of the authors of this abstract were employed at the time by Pack Health, a subsidiary of Quest Diagnostics.

Related content

Conference Presentation
Evaluating Patient-Reported Outcomes and Wearable Data among Individuals with Relapsed/Refractory Multiple Myeloma
Conference Presentation
Randomized Phase 2 Study of Digital Life Coaching during Stem Cell Transplantation for Myeloma
Publication
Randomized Phase 2 Study of Digital Life Coaching During Transplantation for Myeloma
On-Demand Webinar
Precision Medicine: Your Role in Advancing the Future of Cancer Care
Conference Presentation
Updated trial in progress: understanding treatment experience of individuals receiving isatuximab using both patient-reported outcomes and wearable data
Conference Presentation
Outcomes of a Digital Health Coaching (DHC) Program for Individuals With Acute Myeloid and Chronic Lymphocytic Leukemia
Publication
A Pilot Feasibility Study of Digital Health Coaching for Men With Prostate Cancer

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.